⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

June 10, 2024Inflammatory Bowel Diseases

Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study

Lorenzo Bertani Luca Antonioli Marco Fornili Vanessa D’Antongiovanni Linda Ceccarelli Luca Carmisciano Laura Benvenuti M.G. Mumolo Andrea Bottari Veronica Pardi G. Baiano Svizzero Laura Baglietto Nicola de Bortoli Massimo Bellini Matteo Fornai Francesco Costa

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

No biomarkers are currently available to predict therapeutic response to ustekinumab (UST) in Crohn's disease (CD). The aim of this prospective study was to identify 1 or more cytokines able to predict mucosal healing in patients with CD treated with UST.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bertani et al. (2024) studied this question.

synapsesocial.com/papers/68e65674b6db6435875e5736 https://doi.org/10.1093/ibd/izae133

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Predictors of Response to Induction Therapy with Ustekinumab in Patients with Ulcerative Colitis: Results from a National Study in GreeceCohort Study · 2026 · 1 citations
2T cell and cytokine signatures as early predictors of response to IL-12/IL-23 inhibition in Crohn’s diseaseOriginal Research · 2026 · 1 citations
3Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot studyPilot Study · 2022 · 10 citations
4Intestinal mRNA expression profiles associated with mucosal healing in ustekinumab-treated Crohn's disease patients: bioinformatics analysis and prospective cohort validation2024 · 4 citations
5Neutrophil count and platelet–lymphocyte ratio as simple predictors of ustekinumab response in patients with Crohn’s disease: a retrospective multicenter studyCohort Study · 2026
6Discovery of intestinal mRNA expression profiles correlated with mucosal healing of ustekinumab patients with Crohn’s disease: bioinformatics analysis and prospective cohort validation2024
7Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach2024 · 6 citations
8Oral Microbiota Associated with Clinical Efficacy of Ustekinumab in Crohn’s disease2024
9Trends in common laboratory markers during pregnancy in women with IBD in clinical remissionInflammatory Bowel Diseases · 2026
10Effects of upadacitinib on lipid profiles and their relationship with inflammation in patients with inflammatory bowel disease: a real-world longitudinal cohort studyInflammatory Bowel Diseases · 2026

More from Inflammatory Bowel Diseases

More from University of Pisa